Batulicin Nusantara Maritim Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Batulicin Nusantara Maritim Tbk trades at Rp930 (market cap 3.22T, 11.6K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp220 (market cap 310.75B, 159.2K 24h volume). The key difference: Batulicin Nusantara Maritim Tbk is far larger — about 10.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (159.2K versus 11.6K). Which is the better fit depends on your goals.
| BESS | DGNS | |
|---|---|---|
Market Cap | 3.22T | 310.75B |
Volume | 11.6K | 159.2K |
Lot | 116 | 1.59K |
Turnover | 10.49M | 34.72M |
Average Price | 904.18 | 218.06 |
Value | 10.49M | 34.72M |
Indicative Equilibrium Price | — | 220 |
Indicative Equilibrium Volume | — | 6 |
Trailing returns across standard periods
Latest headlines on both assets
PT Batulicin Nusantara Maritim Tbk (the “Company”) was established based on Notarial Deed No. 53 dated May 25, 2011 of Muhammad Faried Zain, S.H., M.H., notary in Banjarmasin. The Company’s immediate Parent Company is PT Batulicin Enam Sembilan Transportasi, and its Ultimate Parent Company is PT Batulicin Enam Sembilan. The Company started its commercial operations in 2012.
Read more on BESS →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →